Results 21 to 30 of about 8,896 (223)
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy [PDF]
Archives of Surgery, 2012 Until 2004, we treated peritoneal carcinomatosis with cytoreductive surgery accompanied by perioperative systemic chemotherapy. From October 2004, we decided to initiate a hyperthermic intraperitoneal chemotherapy (HIPEC) program for this condition.To determine the effect of HIPEC on postoperative outcomes at a single institution performing a high ...
Olivier, Turrini +6 more
openaire +2 more sources
Сибирский онкологический журнал, 2022 Gastric cancer (gc) is one of the most common cancers worldwide. The majority of newly diagnosed gastric cancer cases present with distant metastases. Peritoneal carcinomatosis (pc) is the most unfavorable type of progression of primary gc, which occurs ...
V. A. Markovich +10 more
doaj +1 more source
Pleura and Peritoneum, 2022 Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis.
Casella Francesco +10 more
doaj +1 more source
Primary ovarian high-grade endometrial stromal sarcoma: a case report
Journal of Medical Case Reports, 2021 Background Primary ovarian high-grade endometrial stromal sarcoma is a very rare disease. Even though it has poor prognosis, the gold standard treatment has not been established owing to its rarity.
Ji Sun Lee +5 more
doaj +1 more source
Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy [PDF]
, 2017 Background: Incisional hernia formation has been reported as high as 20% within 1 year following midline laparotomy. Since hyperthermic intraperitoneal chemotherapy is likely to impair wound healing, we sought to investigate the incidence of incisional ...
F. Struller +4 more
core +1 more source
World Journal of Surgical Oncology, 2020 Background Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and pancreaticobiliary 9–14 months with systemic chemotherapy.
Natasha Leigh +6 more
doaj +1 more source
Hyperthermic intraperitoneal chemotherapy (HIPEC) [PDF]
, 2013 Hemmer PHJ, Van Leeuwen BL. Hyperthermic intraperitoneal chemotherapy (HIPEC). Huisarts Wet 2013;56(1):36-9.Surgery forms the basis of cancer therapy, and surgical resection sometimes improves survival in metastatic disease. One such surgical approach is
Van Leeuwen, Barbara +2 more
core +1 more source
Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy [PDF]
, 2021 Spontaneous sigmoid colon perforation after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) is a rare complication. It is more commonly seen with mitomycin‐based HIPEC. This case study's patient presented with pus discharge at
Navin Kumar, Mukur Dipi Ray, Kanak Lata
core +1 more source
Technology in Cancer Research & Treatment, 2023 Despite extensive treatment with surgery and chemotherapy many patients with peritoneal metastases from colorectal cancer experience intraperitoneal disease relapse. The α-emitting 224 radium-labelled microparticle radionuclide therapeutic Radspherin® is
Ebbe Billmann Thorgersen MD, PhD +6 more
doaj +1 more source
Rationale for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis [PDF]
, 2004 peer reviewedUp to now, the prognosis of peritoneal carcinomatosis from GI tract cancers remains very poor. Intraperitoneal hyperthermic chemotherapy has been proposed in the prevention or treatment of peritoneal carcinomatosis.
Honore, Pierre +5 more
core +1 more source